Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,399 | 2,224 | 2,822 | 3,919 | 601 |
| Receivables | 2,048 | 2,892 | 5,806 | 4,995 | 3,672 |
| Other current assets | 781 | 55,592 | 56,506 | 57,827 | 57,042 |
| TOTAL | $10,256 | $60,708 | $65,134 | $66,741 | $61,315 |
| Non-Current Assets | |||||
| PPE Net | 2 | N/A | N/A | N/A | N/A |
| Other Non-Current Assets | 4,392 | 5,370 | 4,597 | 4,421 | 233 |
| TOTAL | $4,394 | $5,370 | $4,597 | $4,421 | $233 |
| Total Assets | $14,649 | $66,078 | $69,731 | $71,162 | $61,548 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 148 | 12,760 | 13,080 | 10,521 | 2,528 |
| Accrued Expenses | 362 | N/A | N/A | N/A | N/A |
| TOTAL | $1,143 | $12,760 | $13,080 | $15,435 | $7,442 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 4,872 | 5,830 | 3,697 | N/A |
| Other Non-Current Liabilities | 4,959 | 33,865 | 50,821 | 52,030 | 54,106 |
| TOTAL | $4,959 | $39,385 | $56,651 | $55,727 | $54,106 |
| Total Liabilities | $6,102 | $66,078 | $69,731 | $71,162 | $61,548 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 366 | 366 | 366 | 369 | 394 |
| Common Shares | 73 | N/A | N/A | N/A | N/A |
| Retained earnings | -184 | N/A | N/A | N/A | N/A |
| TOTAL | $8,548 | $0 | $0 | $0 | $0 |
| Total Liabilities And Equity | $14,649 | $66,078 | $69,731 | $71,162 | $61,548 |